Adial Pharmaceuticals, Inc. Employee Benefits and Share-based Compensation
Adial Pharmaceuticals, Inc. (ADIL) reported Employee Benefits and Share-based Compensation of $435.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Notes › Compensation Related Costs
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2024-04-01
- Adial Pharmaceuticals, Inc. employee benefits and share-based compensation for the quarter ending 2023-12-31 was $108.75K.
- Adial Pharmaceuticals, Inc. employee benefits and share-based compensation for the quarter ending 2023-09-30 was $108.75K.
- Adial Pharmaceuticals, Inc. employee benefits and share-based compensation for the quarter ending 2023-06-30 was $108.75K.
- Adial Pharmaceuticals, Inc. employee benefits and share-based compensation for the quarter ending 2023-03-31 was $108.75K, a 16.00% increase year-over-year.
- Adial Pharmaceuticals, Inc. employee benefits and share-based compensation for fiscal 2023 was $435.00K, a 4.52% increase from fiscal 2022.
- Adial Pharmaceuticals, Inc. employee benefits and share-based compensation for fiscal 2022 was $416.20K, a 10.99% increase from fiscal 2021.
- Adial Pharmaceuticals, Inc. employee benefits and share-based compensation for fiscal 2021 was $375.00K.
| Period end | Employee Benefits and Share-based Compensation 3 month | Employee Benefits and Share-based Compensation 6 month | Employee Benefits and Share-based Compensation 9 month | Employee Benefits and Share-based Compensation 12 month |
|---|---|---|---|---|
| 2023-12-31 | $108.75K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $217.50K derived: sum of 2 quarters · filed 2024-04-01 | $326.25K derived: sum of 3 quarters · filed 2024-04-01 | $435.00K 10-K · filed 2024-04-01 |
| 2023-09-30 | $108.75K 10-Q · filed 2023-11-14 | $217.50K derived: sum of 2 quarters · filed 2023-11-14 | $326.25K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $108.75K 10-Q/A · filed 2023-10-30 | $217.50K 10-Q/A · filed 2023-10-30 | ||
| 2023-03-31 | $108.75K 10-Q · filed 2023-05-12 | |||
| 2022-12-31 | $416.20K 10-K · filed 2024-04-01 | |||
| 2022-03-31 | $93.75K 10-Q · filed 2023-05-12 | |||
| 2021-12-31 | $375.00K 10-K · filed 2023-03-30 | |||
| 2018-06-30 | $49.00K 10-Q · filed 2018-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |